How was Mediterranean diet associated with severity of psoriasis?

July 25, 2018

BottomLine: Adherence to a Mediterranean diet, an eating plan filled with fruits and vegetables, legumes, cereals, bread, fish, fruit, nuts and extra-virgin olive oil, may be associated with the severity of the skin condition psoriasis.

Why The Research Is Interesting: Psoriasis is a common chronic inflammatory skin condition. Studies have suggested adherence to a healthy diet, such as the Mediterranean diet, may reduce the risk of long-term systemic inflammation. This study assessed the association between a score that reflected adherence to the Mediterranean diet and the onset or severity of psoriasis.

Who and When: 35,735 respondents who are part of an ongoing, observational web-based questionnaire study launched in 2009, of whom 3,557 reported they had psoriasis; the condition was severe in 878 cases and 299 news cases were recorded as those arising more than two years after inclusion in the study group

What (Study Measures): Patients with psoriasis were identified via online self-completed questionnaire and categorized by disease severity; data on dietary intake were gathered during the first two years of participation in the study group to calculate a score reflecting adherence to a Mediterranean diet from 0 for no adherence to 18 for maximum adherence.

How (Study Design): This was an observational study. Because researchers were not intervening for purposes of the study they cannot control natural differences that could explain the study findings.

Authors: Céline Phan, M.D., of Hôpital Mondor, Créteil, France, and coauthors

Results: There was an "inverse" association between adherence to a Mediterranean diet and the severity of psoriasis, which suggests patients with severe psoriasis adhered less strongly to the Mediterranean diet, even after accounting for other potential mitigating factors.

Study Limitations: Study participants were all volunteers and they may be more concerned about their health than the general population, data were self-reported and some data were missing.

To Learn More: The full study is available on the For The Media website.

For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jamadermatol.2018.2127)

Editor's Note: The study includes a funding/support disclosure. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
To place an electronic embedded link in your story: Link will be live at the embargo time http://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2018.2127

JAMA Dermatology

Related Psoriasis Articles from Brightsurf:

Most psoriasis patients taking immunosuppressants survive COVID-19
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19.

Getting under the skin of psoriasis
Psoriasis afflicts millions of people worldwide, but treatments are limited to small molecules like steroids, which can cause skin thinning and lose their effectiveness over time.

Psoriasis patients' mental health is more than skin-deep
A new study from Umeå University, Sweden, shows that other somatic diseases have even more impact on patients' mental health than their skin symptoms, highlighting the importance of holistic patient care.

Psoriasis: Towards a novel therapeutic approach
Researchers at the Université libre de Bruxelles (ULB) and the Department of Dermatology of the Erasme hospital uncover the importance of VEGFA signaling in the epidermis to mediate psoriasis development.

Insights into psoriasis suggest a new treatment target
Investigators from Brigham and Women's Hospital and the Harvard Stem Cell Institute have uncovered a novel pathway that may explain why skin thickens in psoriasis and suggests new strategies for developing therapies for the condition.

Psoriasis onset determines if psoriatic arthritis patients develop arthritis or psoriasis first
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

Study: Some biologic treatments for psoriasis may be safer for patients
In the largest study of its kind, Erica D. Dommasch, M.D., M.P.H., a dermatologist in the Department of Dermatology at BIDMC, and colleagues found a decreased risk of infection in patients with psoriasis using some of the newer, more targeted medications compared to those taking methotrexate, a drug widely used since the 1960s as a first line treatment for moderate-to-severe psoriasis.

Higher weight increases risk of psoriasis
The higher a person's BMI, the greater the chance of getting psoriasis.

Lipid that aids normal skin turnover may help psoriasis
Topical application of the lipid phosphatidylglycerol, or PG, on a mouse model of psoriasis reduced inflammation as well as characteristic, raised skin lesions, they report in the Journal of Investigative Dermatology.

New insight into the mechanism of the drug against sclerosis and psoriasis
A multidisciplinary research team at Aarhus University has provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important treatments for multiple sclerosis and psoriasis.

Read More: Psoriasis News and Psoriasis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.